{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:52:57Z","timestamp":1766159577072,"version":"3.37.3"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.abb.2024.110262","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T07:49:38Z","timestamp":1733730578000},"page":"110262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["MD simulations for rational design of high-affinity HDAC4 inhibitors \u2013 Analysis of non-bonding interaction energies for building new compounds"],"prefix":"10.1016","volume":"764","author":[{"given":"Varun","family":"Dewaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratik Narain","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utsab","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-2441","authenticated-orcid":false,"given":"Yenamandra S.","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2024.110262_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1021\/acschembio.5b01067","article-title":"Metal-dependent deacetylases: cancer and epigenetic regulators","volume":"11","author":"L\u00f3pez","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.abb.2024.110262_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/CS20120504","article-title":"Histone deacetylases as targets for treatment of multiple diseases","volume":"124","author":"Tang","year":"2013","journal-title":"Clin. Sci."},{"key":"10.1016\/j.abb.2024.110262_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.abb.2024.110262_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2018.00092","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.abb.2024.110262_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.molonc.2012.09.003","article-title":"HDAC inhibitor-based therapies: can we interpret the code?","volume":"6","author":"New","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.abb.2024.110262_bib6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/b703830p","article-title":"Isoform-selective histone deacetylase inhibitors","volume":"37","author":"Bieliauskas","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.abb.2024.110262_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.abb.2024.110262_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.abb.2024.110262_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bmcl.2018.11.009","article-title":"Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor","volume":"29","author":"Luckhurst","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.abb.2024.110262_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/acsmedchemlett.5b00302","article-title":"Potent, selective, and CNS-penetrant tetrasubstituted cyclopropane class IIa histone deacetylase (HDAC) inhibitors","volume":"7","author":"Luckhurst","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.abb.2024.110262_bib11","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41380-019-0366-8","article-title":"Histone deacetylase 4 (HDAC4): a new player in anorexia nervosa?","volume":"24","author":"Sild","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.abb.2024.110262_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13148-018-0549-1","article-title":"HDAC4 in ischemic stroke: mechanisms and therapeutic potential","volume":"10","author":"Kong","year":"2018","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.abb.2024.110262_bib13","doi-asserted-by":"crossref","first-page":"117\/1","DOI":"10.1186\/s13148-018-0549-1","article-title":"Review of HDAC4 in ischemic stroke: mechanisms and therapeutic potential","volume":"10","author":"Kong","year":"2018","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.abb.2024.110262_bib14","doi-asserted-by":"crossref","unstructured":"Z.-H. Kang, C.-Y. Wang, W.-L. Zhang, J.-T. Zhang, C.-H. Yuan, P.-W. Zhao, Y.-Y. Lin, S. Hong, C.-Y. Li, L. Wang, W.-G. Zhu, Histone Deacetylase HDAC4 Promotes Gastric Cancer SGC-7901 Cells Progression via p21 Repression, (n.d.). https:\/\/doi.org\/10.1371\/journal.pone.0098894.","DOI":"10.1371\/journal.pone.0098894"},{"key":"10.1016\/j.abb.2024.110262_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainresbull.2020.06.010","article-title":"Overexpression of HDAC6, but not HDAC3 and HDAC4 in the penumbra after photothrombotic stroke in the rat cerebral cortex and the neuroprotective effects of \u03b1-phenyl tropolone, HPOB, and sodium valproate","volume":"162","author":"V Demyanenko","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.abb.2024.110262_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/adb.12522","article-title":"Novel role and regulation of HDAC4 in cocaine-related behaviors","volume":"23","author":"Penrod","year":"2018","journal-title":"Addiction Biol."},{"key":"10.1016\/j.abb.2024.110262_bib17","first-page":"11","article-title":"CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes Histone deacetylase 4 (HDAC4) \u00b7 Calcium-calmodulin-dependent protein kinase (CaMKII) \u00b7 Protein kinase A (PKA) \u00b7 Ventricular remodeling","volume":"116","author":"Helmstadter","year":"2021","journal-title":"Cardiac hypertrophy"},{"key":"10.1016\/j.abb.2024.110262_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nlm.2015.06.006","article-title":"The Class IIa histone deacetylase HDAC4 and neuronal function: nuclear nuisance and cytoplasmic stalwart?","volume":"123","author":"Fitzsimons","year":"2015","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.abb.2024.110262_bib19","doi-asserted-by":"crossref","unstructured":"D. Yang, C. Xiao, F. Long, Z. Su, W. Jia, M. Qin, M. Huang, W. Wu, R. Suguro, X. Liu, Y. Zhu, HDAC4 regulates vascular inflammation via activation of autophagy, (n.d.). https:\/\/doi.org\/10.1093\/cvr\/cvy051.","DOI":"10.1093\/cvr\/cvy051"},{"key":"10.1016\/j.abb.2024.110262_bib20","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1158\/0008-5472.CAN-10-4111","article-title":"HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer","volume":"71","author":"Stronach","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2024.110262_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.bjc.6605895","article-title":"MicroRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity","volume":"103","author":"Zhang","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.abb.2024.110262_bib22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni.3292","article-title":"The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote TH17 cell-dependent emphysema","volume":"16","author":"Lu","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.abb.2024.110262_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jcp.24492","article-title":"The pivotal role of microRNA-155 in the control of cancer","volume":"229","author":"Chen","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.abb.2024.110262_bib24","doi-asserted-by":"crossref","first-page":"22045","DOI":"10.1074\/jbc.M201736200","article-title":"Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor","volume":"277","author":"Lemercier","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2024.110262_bib25","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1091\/mbc.e08-10-1061","article-title":"Uncoupling stress granule assembly and translation initiation inhibition","volume":"20","author":"Sophie Mokas","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.abb.2024.110262_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/onc.2008.371","article-title":"HDAC4 represses p21WAF1\/Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism","volume":"28","author":"Mottet","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.abb.2024.110262_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijc.22673","article-title":"Breast cancer associated transcriptional repressor PLU-1\/JARID1B interacts directly with histone deacetylases","volume":"121","author":"Barrett","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.abb.2024.110262_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-4-17","article-title":"Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer","volume":"4","author":"Xu","year":"2011","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.abb.2024.110262_bib29","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1038\/onc.2009.274","article-title":"Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells","volume":"28","author":"Song","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.abb.2024.110262_bib30","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/0008-5472.CAN-12-2730","article-title":"Tasquinimod is an allosteric modulator of HDAC4 survival signaling within the compromised cancer microenvironment","volume":"73","author":"Isaacs","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2024.110262_bib31","doi-asserted-by":"crossref","first-page":"26694","DOI":"10.1074\/jbc.M803514200","article-title":"Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain","volume":"283","author":"Bottomley","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2024.110262_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.abb.2024.110262_bib33","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res."},{"year":"2008","series-title":"Version 2008; Chemical Computing Group","key":"10.1016\/j.abb.2024.110262_bib34"},{"key":"10.1016\/j.abb.2024.110262_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"CHARMM: a program for macromolecular energy, minimization, and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2024.110262_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trot","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2024.110262_bib37","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.abb.2024.110262_bib38","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera - a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2024.110262_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jmgm.2016.10.007","article-title":"A comparative study based on docking and molecular dynamics simulations over HDAC-tubulin dual inhibitors","volume":"70","author":"Hassanzadeh","year":"2016","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.abb.2024.110262_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103522","article-title":"Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell lines","volume":"95","author":"Tilekar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.abb.2024.110262_bib41","first-page":"1","article-title":"Investigation of HDAC8-ligands\u2019 intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents","author":"Dewaker","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2024.110262_bib42","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1080\/07391102.2021.1989037","article-title":"Non-bonding energy directed designing of HDAC2 inhibitors through molecular dynamics simulation","volume":"40","author":"Dewaker","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2024.110262_bib43","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2024.110262_bib44","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/07391102.2019.1598497","article-title":"Molecular dynamics study of HDAC8-largazole analogues co-crystals for designing potential anticancer compounds","volume":"38","author":"Dewaker","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2024.110262_bib45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/nar\/gki464","article-title":"H++: a server for estimating pKas and adding missing hydrogens to macromolecules","volume":"33","author":"Gordon","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.abb.2024.110262_bib46","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.abb.2024.110262_bib47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/prot.340230104","article-title":"Zinc binding in proteins and solution: a simple but accurate nonbonded representation","volume":"23","author":"Stote","year":"1995","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.abb.2024.110262_bib48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1021\/acs.jctc.7b00773","article-title":"Extended zinc AMBER force field (EZAFF)","volume":"14","author":"Yu","year":"2018","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.abb.2024.110262_bib49","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/ci300363c","article-title":"Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.abb.2024.110262_bib50","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1021\/ci3003649","article-title":"Automation of the CHARMM general force field (CGenFF) II: assignment of bonded parameters and partial atomic charges","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.abb.2024.110262_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field : a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2024.110262_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.abb.2024.110262_bib53","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/bioinformatics\/btw215","article-title":"CaFE: a tool for binding affinity prediction using end-point free energy methods","volume":"32","author":"Liu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.abb.2024.110262_bib54","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1021\/ct400065j","article-title":"On the dielectric \u201cconstant\u201d of proteins: smooth dielectric function for macromolecular modeling and its implementation in DelPhi","volume":"9","author":"Li","year":"2013","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.abb.2024.110262_bib55","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.abb.2024.110262_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmgm.2015.09.010","article-title":"Entropy in bimolecular simulations: a comprehensive review of atomic fluctuations-based methods","volume":"62","author":"Kassem","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.abb.2024.110262_bib57","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1080\/07391102.2017.1344568","article-title":"Novel urushiol derivatives as HDAC8 inhibitors: rational design, virtual screening, molecular docking and molecular dynamics studies","volume":"36","author":"Zhou","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2024.110262_bib58","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/07391102.2018.1441072","article-title":"Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking","volume":"37","author":"Sixto-L\u00f3pez","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.abb.2024.110262_bib59","doi-asserted-by":"crossref","first-page":"W48","DOI":"10.1093\/nar\/gkaa235","article-title":"ProteinsPlus: interactive analysis of protein\u2013ligand binding interfaces","volume":"48","author":"Sch\u00f6ning-Stierand","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.abb.2024.110262_bib60","doi-asserted-by":"crossref","first-page":"21246","DOI":"10.1039\/C6CP03144G","article-title":"A salt bridge turns off the foot-pocket in class-II HDACs","volume":"18","author":"Zhou","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.abb.2024.110262_bib61","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1021\/jm4011884","article-title":"Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for huntington's disease","volume":"56","author":"B\u00fcrli","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.abb.2024.110262_bib62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","article-title":"Beware of docking","volume":"36","author":"Chen","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.abb.2024.110262_bib63","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124003849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124003849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T10:27:27Z","timestamp":1737282447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986124003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":63,"alternative-id":["S0003986124003849"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2024.110262","relation":{},"ISSN":["0003-9861"],"issn-type":[{"type":"print","value":"0003-9861"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MD simulations for rational design of high-affinity HDAC4 inhibitors \u2013 Analysis of non-bonding interaction energies for building new compounds","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2024.110262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110262"}}